It is indicated for the treatment of bacterial infections complicated by inflammatory processes caused by microorganisms sensitive to the combination penicillin-dicloxacillin-streptomycin such as: streptococci, pneumococci, staphylococci, Corynebacterium , Pasteurella , Haemophilus , Klebsiellaand Listeria . This antibiotic combination has therapeutic value in diseases of the respiratory system, urogenital organs, mammary gland, muscular system, gastrointestinal tract, septicemic infections and those associated with surgical or traumatic wounds. Do not administer to horses destined for human consumption.
Each 25 mL of reconstituted suspension contains: | ||
---|---|---|
Penicillin G benzatine | . . . . . . . . . . . . . . . . . . . . | 3'500,000 IU |
Procaine penicillin G | . . . . . . . . . . . . . . . . . . . . | 1'500,000 IU |
Streptomycin base (as streptomycin sulfate) | . . . . . . . . . . . . . . . . . . . . | 4 g |
Dicloxacillin sodium | . . . . . . . . . . . . . . . . . . . . | 200 mg |
Dexamethasone | . . . . . . . . . . . . . . . . . . . . | 10 mg |
Sterile injectable water | . . . . . . . . . . . . . . . . . . . . | 20 mL |
SPECIES